GREENVILLE, SC – July 19, 2017 – Amid the heated debates and uncertainty regarding the repeal of the Affordable Care Act (ACA) and the fate of the Better Care Reconciliation Act, Quantros, Inc., emphasizes that regardless of the legislative outcome, payments and reimbursement throughout the healthcare ecosystem are increasingly and decisively linked to the quality of care that is delivered, documented and measured.
“In the absence of consensus on Capitol Hill, the confluence of clinical and financial performance remains intact under the Medicare Access and CHIP Reauthorization Act,” says Andy Weissberg, senior vice president, marketing communications, Quantros, the healthcare industry’s leading provider of performance measurement and management solutions.
For most hospitals and health systems, unwarranted variation in care is a significant source of suboptimal outcomes and unnecessarily high costs that apply to all patients across their case mix and payer mix. Apart from the penalties linked to excess readmissions and hospital-acquired conditions in federal programs, emerging value mandates from both private purchasers and commercial payers narrow the margin for error, and provide even stronger incentives to pinpoint and address the most sensitive areas of undesirable variation in care.
Later this summer, Quantros plans to launch its new enterprise performance management solution, Quantros® Performance Advisor™, which features executive dashboards and drill-downs that provide a line of sight into risk-adjusted measures of quality, including patient safety, patient satisfaction, complications, excess all-site readmissions and others linked to value-based payments and reimbursement across a hospital and health system’s payer mix. Value-seeking healthcare purchasers can also utilize the new Quantros offerings to reliably assess and compare quality and safety performance for virtually all acute care hospitals and physicians in the U.S. across dozens of clinical categories, diagnoses, procedures and areas of treatment.
“Irrespective of whether patients are insured, underinsured or uninsured under any newly proposed or future healthcare reforms, improving patient care outcomes remains the key to achieving clinical and financial success and survival,” adds Weissberg. “We’re proud to serve the industry as the most innovative and reliable resource for measuring value and improving performance in the emerging value-based healthcare economy.”